The Crucial Role of Phase I Clinical Trials in Advancing Medicine; by David Walling, PhD The journey from a promising scientific discovery to a safe and effective medication available to the public is a complex and rigorous process. At the heart of this...
News at CenExel
Advancements in Vaccines: Bridging the Past and Future
Advancements in Vaccines: Bridging the Past and Future - by Nelia Sanchez-Crespo, MD The history of vaccines is a testament to the incredible progress we've made in protecting humanity against infectious diseases. From the invention of the smallpox...
Ethnic Bridging: The Who, the When, the Why
In the dynamic realm of clinical drug development, a new star is rising: Ethnic Bridging clinical trials, also known as ethnobridging or Asian bridging clinical trials. Over the past several years, the industry has witnessed a surge in the adoption of these...
Healthy Feet Are Happy Feet-Preventing and Treating Bunions and Ingrown Toenails
As a CenExel Center of Excellence, JBR works with patients who are managing challenging conditions, such as bunions. As a medical researcher in pain management, I have worked with many individuals that have participated in a bunion surgery at our surgical center in SLC, UT, and over the years I have developed a list of preventative treatments that I recommend to patients after surgery to help them keep their feet and toes happy and healthy. Here are my top tips for healthy feet . . .
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™ SAN DIEGO, July 21, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company...
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours - ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to...